Document is current

Any future updates will be listed below

Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50%

Crossref DOI link: https://doi.org/10.1186/s12885-023-11285-4

Published Online: 2023-08-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark